Business
Block Listing Application
GSK plc has applied to the Financial Conduct Authority and the London Stock Exchange for the admission of 250,000 ordinary shares of 31¼p each to the Official List. These shares are being reserved under a block listing and will be issued pursuant to the GlaxoSmithKline plc Share Save Plan 2022, ranking pari passu with existing ordinary shares. Admission is anticipated to become effective on 12 December 2025. Disclaimer*
About this update from Gsk Plc
[{"type":"text","content":"\n\n \nIssued: 11 December 2025, London UK\n \nBlock Listing Application\n\n \n\n \nApplication has been made to the Financial Conduct Authority and the London Stock Exchange plc for a total of 250,000 Ordinary Shares of 31¼p each ('Shares') to be admitted to the Official List.\n \nThe Shares are being reserved under a block listing and will be issued under the GlaxoSmithKline plc Share Save Plan 2022.\n \nWhen issued, the Shares will rank pari passu with the existing Ordinary Shares of 31¼p each.\n \nAdmission is expected to be effective on 12 December 2025.\n \n \n \n \nV A Whyte\nCompany Secretary\n \n11 December 2025\n \n \nAbout GSK\nGSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. Find out more at www.gsk.com.\n \nRegistered in England & Wales:\nNo. 3888792\n \nRegistered Office:\n79 New Oxford Street\nLondon\nWC1A 1DG\n \n\n","length":2739,"tagName":"div"}]